Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

ASH 2021 | Managing post-transplant complications in myeloma

Nico Gagelmann, MD, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, talks on the management of post-transplant complications, highlighting progress in recent years that has enabled the successful management of graft versus host disease (GvHD), one of the most important complications, in many patients. However, more than half of patients still face severe complications and thus, addressing these must continue to be the subject of investigation. This interview took place at the 63rd ASH Annual Meeting and Exposition congress in Atlanta, GA.